In this study, changes in serum levels of HO-1 were investigated because it plays a role in heme catabolism and was found to increase the release of proinflammatory heme after hemolysis and further enhance inflammation by hemolytic products in COVID-19 patients, especially in patients with ARDS [46,47]. The gene discussed is HMOX1; the disease is acute respiratory distress syndrome.